Time-targeted therapy (TTT): Proof of principle using doxorubicin and radiation in a cultured cell system

References

• Boor DJ, Hortobagyl GN. Anthracycline antibiotics in the treatment of cancer. Drugs 1994; 47: 223–58
   PubMedGoogle Scholar
• Hortobagyl GN. Anthracyclines in the treatment of cancer. An overview. Drugs 1997; 54(Suppl 4)1–7
   Google Scholar
• Pauwels OM, Gozy, et al. Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines. Radiother Oncol 1996; 39: 81–6
   PubMedGoogle Scholar
• Kanter PM, Schwartz HS. Adriamycin-induced DNA damage in human leukemia cells. Leuk Res 1979; 3: 277–83
   PubMedGoogle Scholar
• Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem Pharmacol 1999; 57: 727–41
   PubMed Web of Science ®Google Scholar
• Meijer C, Mulder NH, Timmer-Bosscha H, Zijlstra JG, de Vries EG. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Cancer Res 1987; 47: 4613–7
   PubMed Web of Science ®Google Scholar
• Cummings J, Smyth JF. Pharmacology of adriamycin: The message to the clinician. Eur J Cancer Clin Oncol 1988; 24: 579–82
   PubMedGoogle Scholar
• Chevillard S, Vielh P, Campana F, Bastian G, Coppey J. Cytotoxic effects and pharmacokinetic analysis of combined adriamycin and X-ray treatments in human organotypic cell cultures. Anticancer Drugs 1992; 3: 133–7
   PubMedGoogle Scholar
• Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M. Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet 2002; 41: 431–44
   PubMed Web of Science ®Google Scholar
• Dearfield KL, Jacobson-Kram D, Brown NA, Williams JR. Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. Mutation Res 1983; 108: 437–9
   PubMed Web of Science ®Google Scholar
• Dearfield KL, Jacobson-Kram D, Huber BE, Williams JR. Induction of sister chromatid exchanges in human and rat hepatoma cell lines by cyclophosphamide and phosphoramide mustard and the effects of cytochrome P450 inhibitors. Biochem Pharmacol 1986; 13: 2190–205
   Google Scholar
• Durand RE. Adriamycin: A possible indirect radiosensitizer of hypoxic tumor cells. Radiology 1976; 119: 217–22
   PubMed Web of Science ®Google Scholar
• Byfield JE, Lee YC, Tu L. Molecular interactions between adriamycin and x-ray damage in mammalian tumor cells. Int J Cancer 1977; 19: 186–93
   PubMedGoogle Scholar
• Byfield JE, Lynch M, Kulhanian F, Chan PY. Cellular effects of combined adriamycin and x-irradiation in human tumor cells. Int J Cancer 1977; 19: 194–204
   PubMedGoogle Scholar
• Harris JW, Shrieve DC. Effects of adriamycin and X-rays on euoxic and hypoxic EMT-6 cells in vitro. Int J Radiat Oncol Biol Phys 1979; 5: 1245–8
   PubMedGoogle Scholar
• Rowley R, Bacharach M, Hopkins HA, MacLeod M, Ritenour R, Moore JV, et al. Adriamycin and X-radiation effects upon an experimental solid tumor resistant to therapy. Int J Radiat Oncol Biol Phys 1979; 5: 1291–5
   PubMedGoogle Scholar
• Siemann DW, Sutherland RM. The interaction between adriamycin and radiation in a solid murine tumor. Radiat Res 1980; 83: 345–5
   PubMedGoogle Scholar
• Twentyman PR, Walls GA, Wright KA. The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays. Br J Cancer 1984; 50: 625–31
   PubMed Web of Science ®Google Scholar
• Peacock JH, Shipley WU, Steel GG, Stephens TC. Adriamycin sensitivity following “ultra” low dose rate irradiation of Lewis lung carcinoma in vivo. Int J Radiat Oncol Biol Phys 1985; 11: 2099–104
   PubMedGoogle Scholar
• Chae HJ, Kim HR, Lee WG, Kwak YK, Kim WH, Hong ST, et al. Radiation protects adriamycin-induced apoptosis. Immunopharmacol Immunotoxicol 2005; 27: 211–32
   PubMed Web of Science ®Google Scholar
• Elkind Sutton. X-ray damage and recovery in mammalian cells in culture. Nature 1959; 184: 1293–5
   PubMed Web of Science ®Google Scholar
• Lee SM, Yuon BH, Kim CS, Kim CS, Kang CH, Kim J. Gamma-irradiation and doxorubicin treatment of normal cells cause cell cycle arrest via different pathways. Mole Cells 2005; 20: 331–8
   Google Scholar
• Thielman HW, Popanda O. Doxorubicin and gamma rays increase the level of DNA topoisomerase II alpha in nuclei of normal and xeroderma pigmentosum fibroblasts. J Cancer Res Clin Oncol 1998; 124: 355–66
   PubMedGoogle Scholar
• Chapman, JD. Single hit mechanisms of tumour cell killing by radiation. Int J Radiat Biol 2003 Feb;79(2)71–81.
   PubMed Web of Science ®Google Scholar
• Ertmann R, Erb N, Steinhoff A, Landbeck G. Pharmacokinetics of doxorubicin in man: Dose and schedule dependence. J Cancer Res Clin Oncol 1988; 114: 509–13
   PubMedGoogle Scholar